9d36: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,328,572 edits
No edit summary
Line 1: Line 1:
'''Unreleased structure'''


The entry 9d36 is ON HOLD  until Paper Publication
==Structure of the C-terminal Domain of RAGE and Its Inhibitor==
 
<StructureSection load='9d36' size='340' side='right'caption='[[9d36]]' scene=''>
Authors: Theophall, G.G., Ramasamy, R., Schmidt, A.M., Manigrasso, M., Shekthman, A.
== Structural highlights ==
 
<table><tr><td colspan='2'>[[9d36]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9D36 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9D36 FirstGlance]. <br>
Description: Structure of the C-terminal Domain of RAGE and Its Inhibitor
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 20 models</td></tr>
[[Category: Unreleased Structures]]
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A1A2E:4-[(morpholin-4-yl)methyl]-2-{4-[(2R)-5-oxopyrrolidin-2-yl]phenyl}quinoline-7-carbonitrile'>A1A2E</scene></td></tr>
[[Category: Manigrasso, M]]
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9d36 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9d36 OCA], [https://pdbe.org/9d36 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9d36 RCSB], [https://www.ebi.ac.uk/pdbsum/9d36 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9d36 ProSAT]</span></td></tr>
[[Category: Ramasamy, R]]
</table>
[[Category: Schmidt, A.M]]
== Function ==
[[Category: Shekthman, A]]
[https://www.uniprot.org/uniprot/RAGE_HUMAN RAGE_HUMAN] Mediates interactions of advanced glycosylation end products (AGE). These are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. Acts as a mediator of both acute and chronic vascular inflammation in conditions such as atherosclerosis and in particular as a complication of diabetes. AGE/RAGE signaling plays an important role in regulating the production/expression of TNF-alpha, oxidative stress, and endothelial dysfunction in type 2 diabetes. Interaction with S100A12 on endothelium, mononuclear phagocytes, and lymphocytes triggers cellular activation, with generation of key proinflammatory mediators. Interaction with S100B after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling (By similarity). Receptor for amyloid beta peptide. Contributes to the translocation of amyloid-beta peptide (ABPP) across the cell membrane from the extracellular to the intracellular space in cortical neurons. ABPP-initiated RAGE signaling, especially stimulation of p38 mitogen-activated protein kinase (MAPK), has the capacity to drive a transport system delivering ABPP as a complex with RAGE to the intraneuronal space.<ref>PMID:19906677</ref>
[[Category: Theophall, G.G]]
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Manigrasso M]]
[[Category: Ramasamy R]]
[[Category: Schmidt AM]]
[[Category: Shekthman A]]
[[Category: Theophall GG]]
Retrieved from "https://proteopedia.org/9d36"